Eli Lilly (LLY)

Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure.

Lilly's weight loss drugs have been delivering blockbuster revenue.

Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) will be announcing earnings results this Tuesday before the bell. Here’s what to loo...

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know. Pfizer beat analys...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting results this Tuesday after market hours. Here’s what you need to know. Jazz Pharmaceut...

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be announcing earnings results this Tuesday after the bell. Here’s what to look ...

A new weight loss pill is expanding the pharmaceutical leader's already massive market opportunity.

Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%.

Veeva Systems stock pops following S&P 500 inclusion announcement.

Major M&A deals this week include: Eli Lilly buys Profluent for $2.2 billion, Lazard buys Campbell Lutyens, FreshRealm bankruptcy.

The prescription data collected for Eli Lilly's new weight-loss pill, Foundayo, is flawed, analysts said Friday.

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.3% in the morning session after the stock continued to rally as the comp...

Eli Lilly stock jumps on strong Q1 performance numbers, with its GLP-1s leading the chart.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.5% year on year to $19...

Gary Black calls Eli Lilly's valuation 'compelling' as Q1 earnings soar, driven by the consumer 'love affair' with GLP-1 weight loss drugs.

Eli Lilly stock rallies as GLP-1 sales drive a 56% year-on-year increase in Q1 revenue. Jim Cramer recommends buying LLY shares as the weight-loss addressable market is truly huge.

Eli Lilly (LLY) Q1 2026 Earnings Transcript

GLP-1 drugs turned Lilly into a powerhouse. Now it's time to write the next chapter -- in cancer.